A Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
Obesity
- Phase
- Phase 4
- Status
- Recruiting
- Enrollment
- 3,000 Estimated
- Expected completion
- Jul 2032
- Record updated
- Sep 9, 2026
- Lead sponsor
- Eli Lilly and Company